Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profiles

Ann N Y Acad Sci. 1988:544:387-91. doi: 10.1111/j.1749-6632.1988.tb40431.x.
No abstract available

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Antifungal Agents / toxicity
  • Candida / drug effects
  • Candidiasis, Vulvovaginal / drug therapy*
  • Disease Models, Animal
  • Female
  • Fungi / drug effects
  • Isoxazoles / pharmacology
  • Isoxazoles / therapeutic use*
  • Isoxazoles / toxicity
  • Ketoconazole / pharmacology
  • Ketoconazole / therapeutic use*
  • Ketoconazole / toxicity
  • Microbial Sensitivity Tests
  • Oxazoles / therapeutic use*
  • Rats

Substances

  • Antifungal Agents
  • Isoxazoles
  • Oxazoles
  • PR 967234
  • PR 969566
  • PR 967248
  • Ketoconazole